GridAI Technologies Corp.
GRDX Healthcare Biotechnology
GridAI Technologies Corp.’s revenue for fiscal 2025 (year ended December 2025) was $36,300.00. In the quarter to June 2026, EPS fell 219.0%, free cash flow fell 2,641.0% and total debt fell 64.0%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
Follow GRDX
GridAI Technologies Corp. (GRDX) Dividend Safety Score
GridAI Technologies Corp.'s Dividend Safety Score for fiscal 2025 cannot be worked out: does not pay a regular dividend.
Dividend Safety Score, annual
Annual newest first
| Period | Dividend Safety Score | Change (points) |
|---|
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Payout of earnings earnings at or below zero | — | — | Fail | 0 |
| Payout of free cash flow free cash flow at or below zero | — | — | Fail | 0 |
| Net debt / EBITDA net cash | — | — | Pass | 20 |
| Years without a dividend cut | 0 | — | Fail | 0 |
| Years of falling or negative earnings over the last 10 fiscal years | 10 | — | Fail | 0 |
| Dividend Safety Score | n/a — does not pay a regular dividend | — | ||
How the stockrow Dividend Safety Score works
Our own composite, out of 100, for the latest fiscal year: up to 25 points for how little of its earnings the dividend takes, 25 for how little of its free cash flow, 20 for net debt against EBITDA, 20 for the years it has paid without a cut and 10 for how steady earnings per share have been over ten years. How we calculate it.
| 80–100 | Well covered |
|---|---|
| 60–79 | Adequately covered |
| 40–59 | Stretched |
| below 40 | Weakly covered |
Not worked out for a company that pays no regular dividend, for banks and REITs, whose payouts and leverage these measures do not describe, or with fewer than five years of earnings.
Dividend Safety Score against peers
| Company | Dividend Safety Score |
|---|---|
| ALGS Aligos Therapeutics, Inc. compare | — |
| BCTX BRIACELL THERAP compare | — |
| GRDX GridAI Technologies Corp. | — |
| NXTC NextCure, Inc. compare | — |
| GNTA Genenta Science S.p.A. Unsponsored ADR compare | — |
| ATNM Actinium Pharmaceuticals, Inc. compare | — |
| MGX Metagenomi Therapeutics, Inc. compare | — |
| RNAZ TransCode Therapeutics Inc. compare | — |
| CVM Cel-Sci Corporation compare | — |
What Dividend Safety Score is
The stockrow Dividend Safety Score rates how well earnings and free cash flow cover the dividend, with leverage, the dividend’s record and stable earnings.
Up to 25 points for the payout of earnings, 25 for the payout of free cash flow, 20 for net debt ÷ EBITDA, 20 for the years without a dividend cut and 10 for stable earnings